Clinical Trial Update: Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry

View source ↗

Summary

A completed pregnancy registry study evaluating a meningococcal quadrivalent CRM-197 conjugate vaccine with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Meningococcal Quadrivalent CRM-197 Conjugate Vaccine (CRM-197 conjugate meningococcal vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Meningococcal Disease, Pregnancy | Status: COMPLETED | Results posted: 2019-06-21